Miyaki Michiko, Iijima Takeru, Yamaguchi Tatsuro, Takahashi Keiichi, Matsumoto Hiroshi, Yasutome Michiya, Funata Nobuaki, Mori Takeo
Hereditary Tumor Research Project, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
Int J Cancer. 2007 Oct 1;121(7):1627-30. doi: 10.1002/ijc.22829.
Somatic mutations of the PIK3CA gene have recently been detected in various human cancers, including sporadic colorectal cancer. However, mutations of the PIK3CA gene in hereditary colorectal cancers have not been clarified. To elucidate the mutation status in familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC), which are the most common hereditary colorectal cancers, we investigated PIK3CA mutations in 163 colorectal tumors, including adenomas, intramucosal carcinomas and invasive carcinomas. For comparison, we also analyzed mutations of the same gene in 160 sporadic colorectal tumors at various histopathological stages. Analysis at exons 1, 7, 9 and 20 of the PIK3CA gene revealed somatic mutations in 21% (8 of 39) of FAP invasive carcinomas, 21% (7 of 34) of HNPCC invasive carcinomas, 15% (8 of 52) of sporadic invasive carcinomas, and 14% (7 of 50) of sporadic colorectal metastases in the liver. Mutations in FAP and HNPCC carcinomas predominantly occurred in the kinase domain (exon 20), while the majority of mutations in sporadic cases occurred in the helical domain (exon 9). Adenomas and intramucosal carcinomas from all patients exhibited no mutations (0 of 148). Our data suggest that PIK3CA mutations contribute to the invasion step from intramucosal carcinoma to invasive carcinoma in colorectal carcinogenesis in FAP and HNPCC patients at a similar extent to that seen in sporadic patients.
最近在包括散发性结直肠癌在内的各种人类癌症中检测到了PIK3CA基因的体细胞突变。然而,遗传性结直肠癌中PIK3CA基因的突变情况尚未明确。为了阐明家族性腺瘤性息肉病(FAP)和遗传性非息肉病性结直肠癌(HNPCC)这两种最常见的遗传性结直肠癌的突变状态,我们调查了163例结直肠肿瘤中的PIK3CA突变情况,这些肿瘤包括腺瘤、黏膜内癌和浸润性癌。作为对照,我们还分析了160例处于不同组织病理学阶段的散发性结直肠肿瘤中同一基因的突变情况。对PIK3CA基因第1、7、9和20外显子的分析显示,FAP浸润性癌中有21%(39例中的8例)、HNPCC浸润性癌中有21%(34例中的7例)、散发性浸润性癌中有15%(52例中的8例)以及肝脏散发性结直肠转移瘤中有14%(50例中的7例)存在体细胞突变。FAP和HNPCC癌中的突变主要发生在激酶结构域(第20外显子),而散发性病例中的大多数突变发生在螺旋结构域(第9外显子)。所有患者的腺瘤和黏膜内癌均未显示突变(148例中的0例)。我们的数据表明,在FAP和HNPCC患者的结直肠癌发生过程中,PIK3CA突变对从黏膜内癌到浸润性癌的侵袭步骤的影响程度与散发性患者相似。